Mycobacterium avium complex infection epidemiology and demographics: Difference between revisions
Created page with "__NOTOC__ {{Mycobacterium avium complex infection}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to learn ab..." |
|||
| Line 9: | Line 9: | ||
== Epidemiology and Demographics == | == Epidemiology and Demographics == | ||
Not reportable. Population-based data available for Houston and Atlanta metropolitan areas suggest a rate of 1/100,000/year. Incidence is decreasing among HIV- infected patients as a result of new treatment modalities e.g., combination therapy with nucleoside reverse transcriptase inhibitors and protease inhibitors, as well as antimycobacterial prophylaxis. | Not reportable. Population-based data available for Houston and Atlanta metropolitan areas suggest a rate of 1/100,000/year. [[Incidence]] is decreasing among HIV- infected patients as a result of new treatment modalities e.g., combination therapy with [[nucleoside reverse transcriptase inhibitors]] and [[protease inhibitors]], as well as antimycobacterial prophylaxis. | ||
==References== | ==References== | ||
Revision as of 14:01, 1 October 2012
|
Mycobacterium avium complex infection Microchapters |
|
Differentiating Mycobacterium avium complex infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mycobacterium avium complex infection epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Mycobacterium avium complex infection epidemiology and demographics |
|
FDA on Mycobacterium avium complex infection epidemiology and demographics |
|
CDC on Mycobacterium avium complex infection epidemiology and demographics |
|
Mycobacterium avium complex infection epidemiology and demographics in the news |
|
Blogs on Mycobacterium avium complex infection epidemiology and demographics |
|
Directions to Hospitals Treating Mycobacterium avium complex infection |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Epidemiology and Demographics
Not reportable. Population-based data available for Houston and Atlanta metropolitan areas suggest a rate of 1/100,000/year. Incidence is decreasing among HIV- infected patients as a result of new treatment modalities e.g., combination therapy with nucleoside reverse transcriptase inhibitors and protease inhibitors, as well as antimycobacterial prophylaxis.